GLP1R and type 2 diabetes mellitus: Conversely, there is now a large body of evidence showing that treatment with liraglutide or other long-acting GLP-1 RAs exerts beneficial effects on cardiovascular, mortality, and kidney outcomes in people with T2DM [45,46,47,48,49].